NCT00924664 Long Term Safety Study of Tanezumab in Chronic Low Back Pain Status TERMINATED Phase PHASE2
NCT00922766 Effectiveness And Safety Of Dalteparin In Patients With Acute Coronary Syndromes Without ST Elevations In Clinical Practice Status COMPLETED Phase N/A
NCT00921063 A 5-Week Trial Of PD 0332334 And Alprazolam Extended Release Compared To Placebo In Patients With Generalized Anxiety Disorder Status COMPLETED Phase PHASE2
NCT00920946 A Safety and Efficacy Study of Dimebon in Patients With Huntington Disease Status COMPLETED Phase PHASE3
NCT00920816 Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer Status COMPLETED Phase PHASE3
NCT00918580 Study Evaluating 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Children With Sickle Cell Disease Status COMPLETED Phase PHASE3
NCT00918476 Investigation Of The Effect Of Steady State Filibuvir On The Pharmacokinetics Of Oral Contraceptives (Levonorgestrel And Ethinyl Estradiol) Status COMPLETED Phase PHASE1
NCT00918307 Efficacy and Safety of Varenicline Among HIV-infected Patients Status COMPLETED Phase PHASE3
NCT00918164 Evaluation Of The Relative Bioavailability Of PF-04457845 Tablet To Solution Formulation And Food Effect In Healthy Subjects Status COMPLETED Phase PHASE1
NCT00916617 Study Evaluating The Long-Term Safety And Efficacy Of Subcutaneous Bapineuzumab Status TERMINATED Phase PHASE2
NCT00915278 A Safety Study Of A Monoclonal Antibody Against A5B1 Integrin In Solid Tumors Status TERMINATED Phase PHASE1
NCT00914667 The Effect Of Fesoterodine On Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects Status COMPLETED Phase PHASE1
NCT00914641 Bioavailability Study Comparing Modified Release To Immediate Release Apixaban Tablets In Healthy Volunteers Status COMPLETED Phase PHASE1
NCT00914459 Study Evaluating Safety And Efficacy Of Moroctocog Alfa (AF-CC) In Previously Treated Hemophilia A Patients Status COMPLETED Phase PHASE4
NCT00913627 Study Evaluating Ibuprofen 600 mg Extended Release (ER) For Dental Pain Status COMPLETED Phase PHASE2
NCT00913458 Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis Status COMPLETED Phase PHASE4